NASDAQ · AVXL
Anavex Life Sciences Corp.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for AVXL: Nov 24, 2026
Anavex Life Sciences Corp. Common Stock is estimated to report earnings on 11/24/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.11. The reported EPS for the same quarter last year was $-0.11.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Dec 2026 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Mar 2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Jun 2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · BNK Invest · Zacks · The Motley Fool- RTTNews · Oct 16, 2:06 AM EDTFDA Clears Anavex's IND For Blarcamesine In Fragile X Syndrome(RTTNews) – Anavex Life Sciences Corp. (AVXL), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug Application (IND), allowing it to proceed with its planned clinical study of AN
- RTTNews · Aug 25, 10:43 AM EDTAnavex Life Sciences Reports Q3 2026 Results, Returns To Profit On Expense Recovery; Stock Up(RTTNews) – Anavex Life Sciences Corp. (AVXL), a clinical-stage biopharmaceutical company developing therapies for central nervous system diseases, reported financial results for its third fiscal quarter ended June 30, 2026, alongside regulatory and pipeline updates.
- BNK Invest · Jul 10, 12:08 PM EDTFriday Sector Laggards: Biotechnology, DrugsIn trading on Friday, biotechnology shares were relative laggards, down on the day by about 4%. Helping drag down the group were shares of Kyverna Therapeutics, down about 14% and shares of Prime Medicine off about 13.6% on the day. Also lagging the market Friday are drugs sh
- BNK Invest · May 11, 3:33 PM EDTNotable Monday Option Activity: AVXL, OUT, ASIXLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Anavex Life Sciences Corp (Symbol: AVXL), where a total volume of 6,703 contracts has been traded thus far today, a contract volume which is representative of ap
- RTTNews · May 6, 8:09 AM EDTAnavex Life Sciences Names Terrie Kellmeyer As Interim CEO(RTTNews) – Anavex Life Sciences Corp. (AVXL), a clinical-stage biopharmaceutical company, Wednesday announced that it has appointed Terrie Kellmeyer as its Interim Chief Executive Officer.
- RTTNews · Mar 27, 9:42 AM EDTWeekly Buzz: CORT Wins FDA Nod In Cancer; MRK Acquires TERN; INSM Meets Trial Goals But VALN Misses(RTTNews) – This week's biotech landscape witnessed regulatory approvals across the U.S. and Japan, EU withdrawals, mergers, and clinical trial data readouts spanning lung disease, Lyme disease, kidney disease, ovarian cancer and Type 1 Diabetes.
- RTTNews · Mar 25, 11:21 AM EDTAnavex Withdraws EU Application For Blarcamesine In Early Alzheimer's, Stock Down(RTTNews) – Anavex Life Science Corp. (AVXL) announced that it has withdrawn its marketing authorization application for Blarcamesine in the European Union following feedback from regulators. The update reflects a change in the company's regulatory path for investigational Alzhei
- Zacks · Mar 18, 9:40 AM EDTIs AC Immune (ACIU) Outperforming Other Medical Stocks This Year?Here is how AC Immune (ACIU) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.
- Zacks · Mar 2, 9:40 AM ESTIs Alcon (ALC) Stock Outpacing Its Medical Peers This Year?Here is how Alcon (ALC) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.
- Zacks · Feb 12, 12:00 PM ESTAnavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should KnowAnavex Life Sciences (AVXL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks · Feb 12, 9:40 AM ESTIs Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?Here is how Anavex Life Sciences (AVXL) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
- The Motley Fool · Feb 9, 9:48 AM ESTAnavex (AVXL) Q1 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Anavex Life Sciences Corp. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.